Hap Trading, LLC Sesen Bio, Inc. Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.61 $441 - $549	-900 Reduced 0.41%	219,900 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $1,860	2,000 Added 0.91%	220,800 $11,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.89 $6,004 - $14,062	15,800 Added 7.78%	218,800 $54,000
Q1 2022 May 12, 2022	BUY	$0.58 - $0.86 $73,254 - $108,618	126,300 Added 164.67%	203,000 $20,000
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $22,630 - $39,680	31,000 Added 67.83%	76,700 $9,000
Q3 2021 Nov 10, 2021	BUY	$0.77 - $4.91 $14,091 - $89,853	18,300 Added 66.79%	45,700 $2,000
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.66 $2,180 - $4,660	1,000 Added 3.79%	27,400 $35,000
Q1 2021 May 14, 2021	BUY	$1.3 - $3.24 $13,910 - $34,668	10,700 Added 68.15%	26,400 $11,000
Q4 2020 Feb 16, 2021	SELL	$1.01 - $1.77 $22,119 - $38,763	-21,900 Reduced 58.24%	15,700 $4,000
Q3 2020 Nov 13, 2020	BUY	$0.67 - $1.4 $25,192 - $52,640	37,600 New	37,600 $18,000
Q3 2018 Nov 09, 2018	SELL	$1.54 - $2.38 $289,674 - $447,678	-188,100 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$1.04 - $3.29 $195,624 - $618,849	188,100 New	188,100 $18,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.